{"id":29689,"date":"2017-02-01T18:16:44","date_gmt":"2017-02-01T17:16:44","guid":{"rendered":"http:\/\/www.fedaiisf.it\/?p=29689"},"modified":"2017-02-02T17:18:33","modified_gmt":"2017-02-02T16:18:33","slug":"svizzera-farmaci-costeranno-meno","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/svizzera-farmaci-costeranno-meno\/","title":{"rendered":"Swiss. Medicines will cost less"},"content":{"rendered":"<h2>Medicines pricing review can resume after being stalled in December 2015<\/h2>\n<p><a href=\"http:\/\/www.rsi.ch\/news\/svizzera\/I-farmaci-costeranno-di-meno-8660788.html\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">Wednesday 02\/01\/17 \u2013 rsi.ch\/news<\/span><\/a><\/p>\n<p>The triennial review of the <strong>price of medicines reimbursed by health insurance companies<\/strong> can resume: the Federal Council approved the necessary amendments to the ordinance today, Wednesday. Thanks to this and other measures they can be <strong>saved 240 million francs<\/strong>.<\/p>\n<p>In December 2015, the Federal Supreme Court had blocked the periodic review of the tariffs, holding that these could not be established only on the basis of the cost of preparations abroad but <img loading=\"lazy\" decoding=\"async\" class=\"alignright\" src=\"https:\/\/www.vivere-condividere.ch\/wp-content\/uploads\/2016\/09\/BAG-Logo-it.png\" alt=\"Risultati immagini per UFSP Ufficio federale della sanit\u00e0 pubblica\" width=\"414\" height=\"162\" \/>which also had to be taken into account <strong>cost-benefit ratio<\/strong>.<\/p>\n<p>The Executive has now made it known that <strong>therapeutic efficacy <\/strong>And <strong>comparison with abroad <\/strong>they will have a <strong>equal weight <\/strong>to establish the <strong>final cost<\/strong>.<\/p>\n<p>Measures have also been approved for the <strong>cost containment in the generic drug sector<\/strong>: in the future the <strong>price difference <\/strong>with the original preparation will have to be <strong>greater <\/strong>compared to what happens today.<\/p>\n<p>The Federal Office of Public Health (FOPH) is also developing a new reference tariff system for generics, setting a maximum that compulsory health care insurance will have to reimburse.<\/p>\n<p>ats\/mrj<\/p>\n<p style=\"text-align: left;\">Related news:\u00a0<a href=\"http:\/\/www.swissinfo.ch\/ita\/un-gigante-che-cresce_la-svizzera-%C3%A8-sempre-pi%C3%B9-dipendente-dall-industria-farmaceutica\/42930386\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #0000ff;\">Switzerland is increasingly dependent on the pharmaceutical industry<\/span><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Il riesame dei prezzi dei medicinali pu\u00f2 riprendere, dopo essere stato bloccato nel dicembre 2015 mercoled\u00ec 01\/02\/17 &#8211; rsi.ch\/news Il riesame triennale del prezzo dei farmaci rimborsati dalle casse malati pu\u00f2 riprendere: il Consiglio federale ha approvato oggi, mercoled\u00ec, le necessarie modifiche d\u2019ordinanza. Grazie a questa e ad altre misure potranno essere risparmiati 240 milioni &hellip;<\/p>","protected":false},"author":4,"featured_media":5602,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[29],"class_list":["post-29689","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-notizie","tag-prezzo-farmaci"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/29689","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=29689"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/29689\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/5602"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=29689"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=29689"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=29689"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}